Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Predictive Disease Analytics Market 

5.1. COVID-19 Landscape: Predictive Disease Analytics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Predictive Disease Analytics Market, By Component

8.1. Predictive Disease Analytics Market, by Component, 2023-2032

8.1.1 Software & Services

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Hardware

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Predictive Disease Analytics Market, By Deployment

9.1. Predictive Disease Analytics Market, by Deployment, 2023-2032

9.1.1. On-premises

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Cloud-based

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Predictive Disease Analytics Market, By End Users 

10.1. Predictive Disease Analytics Market, by End Users, 2023-2032

10.1.1. Healthcare Payers

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Healthcare Providers

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Other

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Predictive Disease Analytics Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Component (2020-2032)

11.1.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.1.3. Market Revenue and Forecast, by End Users (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Component (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.1.4.3. Market Revenue and Forecast, by End Users (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Component (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.1.5.3. Market Revenue and Forecast, by End Users (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Component (2020-2032)

11.2.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.2.3. Market Revenue and Forecast, by End Users (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Component (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.2.4.3. Market Revenue and Forecast, by End Users (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Component (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.2.5.3. Market Revenue and Forecast, by End Users (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Component (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.2.6.3. Market Revenue and Forecast, by End Users (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Component (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.2.7.3. Market Revenue and Forecast, by End Users (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Component (2020-2032)

11.3.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.3.3. Market Revenue and Forecast, by End Users (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Component (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.3.4.3. Market Revenue and Forecast, by End Users (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Component (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.3.5.3. Market Revenue and Forecast, by End Users (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Component (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.3.6.3. Market Revenue and Forecast, by End Users (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Component (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.3.7.3. Market Revenue and Forecast, by End Users (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Component (2020-2032)

11.4.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.4.3. Market Revenue and Forecast, by End Users (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Component (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.4.4.3. Market Revenue and Forecast, by End Users (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Component (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.4.5.3. Market Revenue and Forecast, by End Users (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Component (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.4.6.3. Market Revenue and Forecast, by End Users (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Component (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.4.7.3. Market Revenue and Forecast, by End Users (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Component (2020-2032)

11.5.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.5.3. Market Revenue and Forecast, by End Users (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Component (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.5.4.3. Market Revenue and Forecast, by End Users (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Component (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Deployment (2020-2032)

11.5.5.3. Market Revenue and Forecast, by End Users (2020-2032)

Chapter 12. Company Profiles

12.1. IBM Corporation

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. SAS Institute Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Optum, Inc. (a subsidiary of UnitedHealth Group)

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Cerner Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. McKesson Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Allscripts Healthcare Solutions, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Oracle Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Microsoft Corporation

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Health Catalyst, LLC

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Epic Systems Corporation

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms